rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Marksans Pharma Ltd. - Research Center
524404 MARKSANS Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Annual results in brief
(Rs crore)
Mar ' 14 Mar ' 13 Mar ' 12 Mar ' 11 Mar ' 10
Sales 318.26 196.47 156.55 157.12 201.17
Operating profit 87.13 48.44 -153.04 -12.32 25.24
Interest 15.21 10.13 11.88 105.77 14.78
Gross profit 71.92 38.31 -164.92 -118.08 10.47
EPS (Rs) 1.44 1.03 -4.92 -5.92 0.01
Annual  results in details
Mar ' 14 Mar ' 13 Mar ' 12 Mar ' 11 Mar ' 10
Other income - - - - -
Stock adjustment -1.84 9.19 10.33 0.04 11.98
Raw material 142.63 65.96 60.50 107.28 -
Power and fuel - - - - -
Employee expenses 21.39 15.39 13.55 11.38 10.69
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 68.95 57.48 225.20 50.74 153.25
Provisions made - - - - -
Depreciation 8.66 8.70 17.98 14.64 9.84
Taxation 7.70 -9.98 -1.84 4.85 0.34
Net profit / loss 55.56 39.58 -181.07 -217.79 0.29
Extra ordinary item - - - -80.22 -
Prior year adjustments - - - - -
Equity capital 38.53 38.53 36.78 36.78 36.78
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) 1878.15 1886.34 1898.24 1898.24 1898.22
Agg.of non promotoholding (%) 48.75 48.96 51.61 51.61 51.61
OPM (%) 27.38 24.66 -97.76 -7.84 12.55
GPM (%) - - - - -
NPM (%) - - - - -
Close
Add Marksans Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Marksans Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close